|
|
| | CTCE 9908 Basic information |
| Product Name: | CTCE 9908 | | Synonyms: | CTCE 9908;L-Lysinamide, N2,N6-bis(L-lysylglycyl-L-valyl-L-seryl-L-leucyl-L-seryl-L-tyrosyl-L-arginyl)-;N2,N6-Bis(L-lysylglycyl-L-valyl-L-seryl-L-leucyl-L-seryl-L-tyrosyl-L-arginyl)-L-lysinamide;CTCE 9908 TFA | | CAS: | 1030384-98-5 | | MF: | C86H147N27O23 | | MW: | 1927.25 | | EINECS: | | | Product Categories: | | | Mol File: | 1030384-98-5.mol |  |
| | CTCE 9908 Chemical Properties |
| storage temp. | Store at -20°C | | solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | | form | Powder |
| | CTCE 9908 Usage And Synthesis |
| Uses | CXCR4 is a chemokine receptor often overexpressed in cancer cells and involved with metastasis. N2,N6-Bis(L-lysylglycyl-L-valyl-L-seryl-L-leucyl-L-seryl-L-tyrosyl-L-arginyl)-L-lysinamide is a CXCR4 antagonist. It inhibits ovarian cancer cell migration to CXCL12 and induces cell death in CXCR4-positive cells. | | storage | Store at -20°C |
| | CTCE 9908 Preparation Products And Raw materials |
|